A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/01/2006	CN1856471A A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline
11/01/2006	CN1856470A 喹啉钾通道抑制剂 Quinoline potassium channel inhibitors
11/01/2006	CN1856469A Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
11/01/2006	CN1856468A Pyridylacetylenes for use as radiotracers and imaging agents
11/01/2006	CN1856467A 2-pyridone derivatives as netrophil elastase inhibitors and their use.
11/01/2006	CN1856465A Amino-substituted ethylamino beta2 adrenergic receptor agonists
11/01/2006	CN1856464A 氨基链烷醇衍生物 Amino alkanol derivative
11/01/2006	CN1856339A Iloprost in combination therapies for the treatment of pulmonary arterial hypertension
11/01/2006	CN1856327A Combination of a VEGF receptor inhibitor with a chemotherapeutic agent
11/01/2006	CN1856314A Farmaceutiske kombinationer af adenosin A-2a- og beta-2-adrenerge receptoragonister
11/01/2006	CN1856313A Therapeutic compounds
11/01/2006	CN1856312A Combination of mGluR2 antagonist and AChE inhibitor for treatment of acute and/or chronic neurological disorders
11/01/2006	CN1856311A 6-aryl-7-halo-imidazo[1,2-A]pyrimidines as anticancer agents
11/01/2006	CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006	CN1856309A Hexa- and octahydro-pyrido[1,2-a] pyrazine derivatives with NK1 antagonistic activity
11/01/2006	CN1856308A Excitatory amino acid receptor antagonists
11/01/2006	CN1856307A Quinoline potassium channel inhibitors
11/01/2006	CN1856306A Aerosol formulation for inhalation comprising an anticholinergic
11/01/2006	CN1856305A Pyridine derivatives and use thereof as urotensin II antagonists
11/01/2006	CN1856304A Derivatives of N-(1H-indazolyl)- and N-(1H-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (VR1) for the treatment of pain
11/01/2006	CN1856303A Compositions for the treatment and prevention of diabetes mellitus
11/01/2006	CN1856302A Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir)
11/01/2006	CN1856301A Curable beta-amino acid
11/01/2006	CN1856300A Methods and materials for treating conditions associated with metabolic disorders
11/01/2006	CN1856294A Penetrating pharmaceutical foam
11/01/2006	CN1856251A Pharmaceutical compositions comprising active vitamin D compounds
11/01/2006	CN1854148A Astragalus total heteroside extract and its production
11/01/2006	CN1854139A Levo ofloxacin derivative, its production and use
11/01/2006	CN1854138A 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
11/01/2006	CN1854135A Heteronuclear compound with dicyandiamide connection and its medicinal use
11/01/2006	CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
11/01/2006	CN1854131A Compounds and method for preparing sustituted 4-phenyl-4-cyanocyclohexanoic acids
11/01/2006	CN1854130A Chinazoline derivative, its production, medicinal composition and use
11/01/2006	CN1854125A Aryl-group-substituted acrylonitrile compound, its production and use
11/01/2006	CN1854122A Blood pool agents for nuclear magnetic resonance diagnostics
11/01/2006	CN1854118A Indane acetic acid compound
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
11/01/2006	CN1853729A Preparation of polynuclear iron hydroxide-sugar composite
11/01/2006	CN1853727A Polysaccharide-containing compositions and use thereof
11/01/2006	CN1853726A Polymer system for improving insoluble medicine water solubility and preparation thereof
11/01/2006	CN1853724A Compound injection with probenecid, potassium and beta-lactam antibiotic and its use
11/01/2006	CN1853723A Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interaction
11/01/2006	CN1853722A Methods for preventing antipsychotic-induced weight gain
11/01/2006	CN1853715A Anshen Bunao soft capasule and preparation thereof
11/01/2006	CN1853714A Wuren alcohol soft capasule and preparation thereof
11/01/2006	CN1853713A Anshen Bunao drip ball and preparation thereof
11/01/2006	CN1853711A Xinmaikangzhong Chinese medicinal composition and preparation thereof
11/01/2006	CN1853705A Medicine for treating cardiovascular disease
11/01/2006	CN1853703A Obtundent healing paste for treating burn and scald
11/01/2006	CN1853699A Chinese medicine for treating burn and scald
11/01/2006	CN1853696A Medicine for treating coronary heart disease and preparation thereof
11/01/2006	CN1853693A Antidiarrheal medicinal composition
11/01/2006	CN1853685A Pearl guttural tablets
11/01/2006	CN1853675A Compound Silybum drip balls and preparation thereof
11/01/2006	CN1853672A Composition containing butylbenzene peptide
11/01/2006	CN1853666A Pharmaceutical, nutraceutical, dietetic and nutritional compositions based on vegetable fibres
11/01/2006	CN1853663A Analgesic
11/01/2006	CN1853648A Intraoral glue composition for releasing dental exulceratio pain
11/01/2006	CN1853647A Use III of sealwort polysaccharide
11/01/2006	CN1853646A Compound three-vitamines B injection and preparation thereof
11/01/2006	CN1853645A Combined preparations comprising morpholine anthracyclines and anticancer agent
11/01/2006	CN1853644A Treatment and prophylaxis of diseases and infections pigs and poultry
11/01/2006	CN1853643A Composition of self-microemulsion puerarin oral preparation and use thereof
11/01/2006	CN1853642A Combined preparations comprising morpholine anthracyclines and anticancer agent
11/01/2006	CN1853641A Glycyrrhiza edulcorant drip ball and production thereof
11/01/2006	CN1853640A Doxycycline hyclate liposome and production thereof
11/01/2006	CN1853639A Medical use of surface active substance
11/01/2006	CN1853638A Methods for treating delirium using glucocorticoid receptor-specific antagonists
11/01/2006	CN1853637A Use of pentacyclic triterpene compound as glycogen phosphorylase inhibitor
11/01/2006	CN1853636A Citric acid Mosabily oral liquid
11/01/2006	CN1853635A Use of triazinetrione sulfones for combating coccidiosis
11/01/2006	CN1853634A Composition comprising itraconazole for oral administration
11/01/2006	CN1853633A USe of beta-FNA in dementia praecox treatment
11/01/2006	CN1853632A Herba fibraurae recisae soft capsules and production thereof
11/01/2006	CN1853631A Fast disintegrant containing paroxetine
11/01/2006	CN1853630A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/01/2006	CN1853629A Berberine dripping balls and preparation thereof
11/01/2006	CN1853628A Preparing method for injection containing benzimidazole derivative
11/01/2006	CN1853627A Cyclodextrin of bibenziisosehenazole ethane or cyclodextrin derivative inclusion compound, and preparation and use thereof
11/01/2006	CN1853626A Zinc sulfate freeze-dried preparation for injection
11/01/2006	CN1853625A Combination of sweet-scented osmanthus and plantinum chemotherapeutic medicine
11/01/2006	CN1853624A Fat emulsion containing tanshinone analog and use thereof
11/01/2006	CN1853623A Use of hellebore alkaloid in tumor treatment
11/01/2006	CN1853622A Use of setooquen
11/01/2006	CN1853621A Use of pinolenic acid
11/01/2006	CN1853620A Fat emulsion of houttuynin analog
11/01/2006	CN1853619A Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders
11/01/2006	CN1853618A Use of bromphenol compound in protein-tyrosine phosphonatease inhibitor
11/01/2006	CN1853617A Medicine based on anti-hyperglycaemic microcapsules with prolonged release
11/01/2006	CN1853615A Tablet containing brufen and producing process thereof
11/01/2006	CN1853614A Decoloring method and decoloring agent for quinolone injection
11/01/2006	CN1853608A Cosmetic/dermatological compositions
11/01/2006	CN1853507A Non-effect components for beverage or solid oral agent or food additive with weight-losing function
11/01/2006	CN1853480A Broad-spectrum antiseptics and production thereof
11/01/2006	CN1282649C Corter pseudolaricis acid derivatives, preparation method and use thereof
11/01/2006	CN1282645C Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
11/01/2006	CN1282644C Indane or indoline derivative
11/01/2006	CN1282643C Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method
11/01/2006	CN1282641C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same

1 ... 4029 4030 4031 4032 4033 4034 4035 4036 4037 4038 4039 4040 4041 4042 4043 4044 4045 4046 4047 4048 4049 ... 7860